These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11548729)

  • 21. Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK.
    Kropff J; Selwood MP; McCarthy MI; Farmer AJ; Owen KR
    Diabetologia; 2011 May; 54(5):1261-3. PubMed ID: 21350841
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for type 2 diabetes. Undiagnosed diabetes must be detected.
    Streets P
    BMJ; 2001 Aug; 323(7310):453-4; author reply 454-5. PubMed ID: 11520852
    [No Abstract]   [Full Text] [Related]  

  • 23. Type 2 diabetes mellitus: issues for the medical care of pediatric and adult patients.
    Beck MJ; Evans BJ; Quarry-Horn JL; Kerrigan JR
    South Med J; 2002 Sep; 95(9):992-1000. PubMed ID: 12356140
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for type 2 diabetes in the Iranian national programme: a preliminary report.
    Azizi F; Guoya MM; Vazirian P; Dolatshati P; Habbibian S
    East Mediterr Health J; 2003; 9(5-6):1122-7. PubMed ID: 16450546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the evidence. Type 2 diabetes.
    Melville A; Richardson R; Lister-Sharp D
    Health Serv J; 2000 Mar; 110(5696):32-3. PubMed ID: 11067500
    [No Abstract]   [Full Text] [Related]  

  • 26. The early detection of colorectal cancer in primary care.
    Jones R; Kennedy T
    Br J Gen Pract; 1999 Dec; 49(449):956-8. PubMed ID: 10824337
    [No Abstract]   [Full Text] [Related]  

  • 27. United Kingdom Prospective Diabetes Study.
    Schmitz OE; Mogensen CE
    Ugeskr Laeger; 1996 Apr; 158(15):2137-9. PubMed ID: 8650790
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for type 2 diabetes.
    American Diabetes Association
    Diabetes Care; 2003 Jan; 26 Suppl 1():S21-4. PubMed ID: 12502615
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for type 2 diabetes. Population screening was not effective in former East Germany.
    Berger M
    BMJ; 2001 Aug; 323(7310):454; author reply 455. PubMed ID: 11548730
    [No Abstract]   [Full Text] [Related]  

  • 30. Why screening for type 2 diabetes is necessary even in poor resource settings.
    Unnikrishnan R; Mohan V
    J Diabetes Complications; 2015; 29(7):961-4. PubMed ID: 26099834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The unrecognized prevalence of chronic kidney disease in diabetes.
    Middleton RJ; Foley RN; Hegarty J; Cheung CM; McElduff P; Gibson JM; Kalra PA; O'Donoghue DJ; New JP
    Nephrol Dial Transplant; 2006 Jan; 21(1):88-92. PubMed ID: 16221715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 34. A practical approach to type 2 diabetes.
    Conlon PC
    Nurs Clin North Am; 2001 Jun; 36(2):193-202, v. PubMed ID: 11382559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to stop talking about screening for diabetes?
    Stephens JW; Williams R
    Diabet Med; 2006 Nov; 23(11):1163-4. PubMed ID: 17054589
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
    Cull CA; Jensen CC; Retnakaran R; Holman RR
    Circulation; 2007 Nov; 116(19):2119-26. PubMed ID: 17967769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetes, hypertension and microalbuminuria in primary care].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians.
    Grant RW; Wexler DJ; Ashburner JM; Hong CS; Atlas SJ
    Arch Intern Med; 2012 May; 172(10):821-3. PubMed ID: 22636827
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race equality. Missing out on monitoring.
    White C
    Health Serv J; 2007 Nov; 117(6084):28-9. PubMed ID: 18220121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.